Maine Cannabis: 187 Stores, 93% Capture, and the Tourism Correction

Maine operates one of the highest-priced full-capture legal markets in the dataset. At $6.12/g pre-tax — above Nevada and Rhode Island — the state still achieves effectively complete resident black market displacement. It then raised its cannabis sales tax 40% in January 2026 and, so far, sales haven't broken. The more instructive story is what happens when 13 million annual tourists inflate sales figures in a small-population state, and why naive TAM calculations for seasonal markets overstate capture rates.

Market Overview

Maine legalized adult-use cannabis under Question 1 in November 2016. First recreational retail sales launched October 9, 2020 after a multi-year implementation delay. The market is regulated by the Office of Cannabis Policy (OCP).

Key metrics:

• 187 active adult-use retail stores (OCP licensee database, July 2026)
• Adult-use revenue: $246.8 million in the most recent full year (+1.2%), across ~4.8 million transactions
• Combined legal market: $502 million ($256.0M medical + $246.1M adult-use per Maine Revenue Services)
• $6.12/g adult-use flower (pre-tax, 2026 YTD — an all-time low)
• 14% point-of-sale tax as of January 1, 2026, with a separate $223/lb cultivation excise embedded upstream
• ~93% resident capture after the tourism correction — effectively full displacement
• $1.32M adult-use revenue per store annually
• 3 mature + 12 immature plants per adult home cultivation permitted (6 mature for registered medical patients)

Flower Pricing

Maine is one of the highest-priced markets in the dataset that still achieve full resident capture. At roughly $6.98/g out the door ($6.12 shelf price × the 14% sales tax), Maine's legal cannabis sits well inside the regional black market range ($5–8/g) but near its upper half. The sharper comparison is Rhode Island: at $6.80 out the door — eighteen cents cheaper than Maine — Rhode Island captures 39% of resident demand. Maine, at effectively the same consumer price, captures nearly all of it. Price matters, but it doesn't operate in isolation from enforcement and access.

*Maine's burden reflects point-of-sale tax only. The state's $223/lb cultivation excise is levied upstream and already embedded in the pre-tax shelf price, so it is not added again to the consumer price.

Tax Structure — Restructured January 2026

Maine uses a two-tier system that is simpler than most states and notably non-compounding. As of January 1, 2026, the Legislature rebalanced it (P.L. 2025, c. 388) — raising the visible retail tax while cutting the upstream cultivation excise:

• Retail sales tax: 14% on adult-use cannabis at the point of sale (up from 10% — a 40% rate increase)
• Cultivation excise: $223/lb for flower, down from $335/lb; trim cut from $94 to $63/lb, with corresponding reductions for plants and seeds

The two layers should not be summed into a single consumer rate: the excise is paid by growers and passes through into the shelf price, so the consumer math is simply shelf price × 1.14 — about $6.98/g out the door at the current $6.12 average. Both changes are visible in Maine Revenue Services data: the effective sales tax rate runs exactly 10.0% through December 2025 and exactly 14.0% from January forward, while monthly excise receipts fell from $1.5–1.7M to $1.1–1.3M.

The consumer impact has been muted anyway, because prices keep falling — out-the-door prices are lower today than before the tax increase. And sales show no break: January–May adult-use sales were $95.2M in 2026 against $95.0M in 2025, flat revenue on ~10% lower prices, which implies unit volume is up. A 4-point visible tax increase producing no detectable sales disruption is consistent with the framework's core claim: at Maine's price point, enforcement and access — not marginal price — are the binding variables.

Total Addressable Market and the Tourism Correction

Maine's adult population is approximately 1.09 million. Applying the empirically validated consumption baseline of 18% participation at 1.0 gram per day:

• 1.09 million adults 21+
• 196,200 estimated regular consumers (18%)
• 71.6 million grams annual resident demand
• Resident TAM: ~$474 million at the $6.62/g average price prevailing during the most recent full sales year

Against that TAM, the combined legal market — $246.1M adult-use plus $256.0M medical, per Maine Revenue Services taxable sales data — totals $502M, an apparent capture of 106%. Capture above 100% requires explanation.

The explanation is 13 million annual overnight tourists. Maine's seasonal visitation pattern is clearly visible in the OCP's monthly data: summer months (June–September) run 35–40% above the winter baseline of stable resident demand. December runs 48–61% above baseline. January and February track close to the winter floor.

Attributing the seasonal excess above the winter-resident baseline to non-resident purchasing yields an estimated 12.5% of total sales — approximately $63 million annually. Stripping that out puts resident capture at roughly 93%: effectively full displacement, with a ±3-point tourism-share band spanning roughly 90–96%. (The baseline must be computed from OCP's monthly METRC data; MRS monthly reports spike at quarter-ends from quarterly filers.) The non-resident component is structurally sustainable, driven by Maine's 280-mile border with New Hampshire, where adult-use remains prohibited — the NH Senate tabled the House-passed legalization bill again in March 2026.

Why this matters for other small tourist states: The same inflation that makes Maine look like a 106% capture market would affect Montana, Vermont, or any jurisdiction where seasonal visitors meaningfully exceed the resident population. Hawaii's market analysis illustrates the inverse problem — overestimating how much tourism drives capture in a medical-only program where the structural barriers prevent tourists from participating at scale. Maine's data provides the corrective: tourism is real and measurable through seasonality, but it needs to be isolated before drawing conclusions about resident demand.

Revenue Trend

The plateau is only half the picture. Maine's medical program peaked at $372M in 2021 and has declined every year since, to $256.0M in 2025 (−31% from peak), as spending migrates to the adult-use channel; the combined market peaked in 2024 and contracted 2.5% in 2025. This is the Oregon/Colorado pattern — growth driven entirely by volume as prices compress, not new consumer acquisition — and the OCP has characterized it as market maturity and mild oversaturation. At 187 stores for 196,200 estimated consumers, Maine has roughly 1,049 consumers per store, converging toward Oregon's 767.

Dispensary Density

Per-store revenue is adult-use revenue over active adult-use stores ($246.8M ÷ 187). A previous version reported $2.87M/store by dividing combined medical + adult-use revenue by the adult-use store count — mixed denominators, since medical flows through a separate layer of 94 dispensary storefronts plus caregiver retail.

Maine's $1.32M per-store revenue sits just above Oregon's unsustainable $1.20M floor — the third-densest retail network in the dataset, still adding stores into flat demand. This is Oregon-style saturation economics: full capture achieved, consumer acquisition complete, per-store revenue compressing.

The geographic distribution remains the structural strength — dispensaries operate in 16 of Maine's counties, including remote counties with fewer than 20,000 residents, though Cumberland and York alone hold 76 of the 187 stores (41%). Statewide access is why full capture is achievable at these prices: rural consumers can buy legal without inconvenience, removing the geographic advantage that sustains unlicensed markets in states like California. The same density that makes Maine excellent at displacement makes it mediocre at per-store returns.

Home Cultivation

Maine law allows adults 21+ to cultivate 3 mature plants plus 12 immature plants (and unlimited seedlings), with registered medical patients permitted 6 mature plants — a moderately permissive home grow policy. Despite these rights, participation rates are negligible across every market. Maine's outdoor growing climate limits harvests to fall months, and the legal retail network provides the quality assurance and product variety that makes commercial cultivation economically rational for the vast majority of consumers. Home grow has had no measurable impact on Maine's revenue trajectory.

What the CHS Literature Missed

Maine has an unusually layered consumer health infrastructure for a small-population state: the Maine CDC cannabis page, the OCP-required dispensary prevention sign, and the state-funded Good to Know Maine consumer campaign. All three cover youth brain development, pregnancy, driving impairment, accidental ingestion, and safe storage. None of them mention CHS by name.

Good to Know Maine's safe use page does list "severe nausea/vomiting" among the symptoms of taking too much cannabis — but frames it as a general overconsumption effect, not a distinct syndrome associated with chronic heavy use. The OCP's required dispensary signage covers seven consumer safety topics. CHS is not one of them.

The only Maine source that names CHS directly is a hospital news report describing it as a "rare, serious condition" linked to heavy cannabis use — the same characterization that emerged from the University of Illinois Chicago research cited in the Illinois analysis. Maine's official consumer health infrastructure, across three separate channels covering an estimated 196,200 regular consumers, treats vomiting as an overconsumption symptom rather than a syndrome warranting its own disclosure. That framing is consistent with what population-level behavioral analysis shows about actual CHS prevalence among regular consumers.

The Bottom Line

Maine is the proof that full capture isn't a function of price alone. Rhode Island and Maine sell legal cannabis at nearly identical out-the-door prices — $6.80 versus $6.98 — and Rhode Island captures 39% of resident demand while Maine captures effectively all of it. The difference isn't the eighteen cents. It's statewide retail access, functional enforcement, and zero unlicensed storefronts. And when Maine raised its visible sales tax 40% in January 2026, sales didn't break.

The tourism data is the other lesson. 13 million annual overnight visitors create a real, measurable non-resident component — visible in seasonal spikes of 35–48% above the winter baseline — that inflates aggregate capture for any small-population state with heavy visitation. Strip it out and resident capture lands at roughly 93%: effectively full displacement.

But full capture is a consumer-side victory and an operator-side ceiling. At $1.32M per store with 187 stores chasing flat demand, complete displacement means the growth is over. What's left is a knife fight over a fixed pie.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.